Nurix Therapeutics (NRIX) Insider Trading & Ownership $22.05 -0.32 (-1.43%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Nurix Therapeutics (NASDAQ:NRIX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$2.22 M Get NRIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Nurix Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NRIX Insider Buying and Selling by Quarter Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Nurix Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/1/2024Houte Hans VanCFOSell3,546$24.28$86,096.88 10/30/2024Gwenn HansenInsiderSell3,437$24.30$83,519.10 10/30/2024Houte Hans VanCFOSell2,368$24.30$57,542.40 10/14/2024Christine RingInsiderSell3,290$25.00$82,250.00 10/1/2024Christine RingInsiderSell5,760$22.23$128,044.80 9/3/2024Christine RingInsiderSell9,050$24.94$225,707.00 Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide8/26/2024Christine RingInsiderSell9,870$25.01$246,848.70 8/26/2024Houte Hans VanCFOSell20,000$25.22$504,400.00 8/1/2024Christine RingInsiderSell5,760$21.43$123,436.80 8/1/2024Houte Hans VanCFOSell3,477$21.45$74,581.65 7/30/2024Gwenn HansenInsiderSell3,408$20.67$70,443.36 7/30/2024Houte Hans VanCFOSell2,490$20.67$51,468.30 7/1/2024Christine RingInsiderSell5,760$20.81$119,865.60 6/12/2024Christine RingInsiderSell1,900$17.01$32,319.00 6/5/2024Christine RingInsiderSell400$17.00$6,800.00 6/3/2024Christine RingInsiderSell1,596$17.01$27,147.96 5/2/2024Houte Hans VanCFOSell3,499$12.83$44,892.17 4/30/2024Gwenn HansenInsiderSell2,007$12.04$24,164.28 4/30/2024Houte Hans VanCFOSell1,387$12.04$16,699.48 2/16/2024Houte Hans VanCFOSell6,812$10.02$68,256.24 1/30/2024Gwenn HansenInsiderSell2,334$7.99$18,648.66 1/30/2024Houte Hans VanCFOSell1,671$7.99$13,351.29 12/19/2023Houte Hans VanCFOSell10,906$10.00$109,060.00 (Data available from 1/1/2013 forward) NRIX Insider Trading Activity - Frequently Asked Questions Who is on Nurix Therapeutics's Insider Roster? The list of insiders at Nurix Therapeutics includes Christine Ring, Gwenn Hansen, Houte Hans Van, and Stefani Wolff. Learn more on insiders at NRIX. What percentage of Nurix Therapeutics stock is owned by insiders? 7.20% of Nurix Therapeutics stock is owned by insiders. Learn more on NRIX's insider holdings. Which Nurix Therapeutics insiders have been selling company stock? The following insiders have sold NRIX shares in the last 24 months: Christine Ring ($1,029,256.86), Gwenn Hansen ($242,813.04), Houte Hans Van ($1,061,986.86), and Stefani Wolff ($8,373.68). How much insider selling is happening at Nurix Therapeutics? Insiders have sold a total of 124,078 Nurix Therapeutics shares in the last 24 months for a total of $2,342,430.44 sold. Nurix Therapeutics Key ExecutivesDr. Arthur T. Sands M.D. (Age 62)Ph.D., CEO, President & Director Compensation: $986.32kMr. Johannes Van Houte (Age 58)Chief Financial Officer Compensation: $681.98kDr. Gwenn M. Hansen Ph.D. (Age 53)Chief Scientific Officer Compensation: $702.75kDr. John Kuriyan Ph.D.Founder & Member of Scientific Advisory BoardMr. Michael Rapé Ph.D.Founder & Member of Scientific Advisory BoardDr. Arthur Weiss M.D.Ph.D., Founder & Member of Scientific Advisory BoardRita KwongSenior Accounting ManagerDr. Christine Ring J.D. (Age 59)Ph.D., Chief Legal Officer, Secretary & Chief Compliance Officer Compensation: $595.83kMr. Eric C. Schlezinger J.D. (Age 57)Chief People Officer Dr. Jason Kantor Ph.D.Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies ARVN Insider Trades PRAX Insider Trades LGND Insider Trades CMPS Insider Trades BPMC Insider Trades LNTH Insider Trades NUVL Insider Trades VKTX Insider Trades CYTK Insider Trades TGTX Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:NRIX) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
